To compare the outcomes of revisional Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB) after failed laparoscopic sleeve gastrectomy (LSG) in terms of weight loss, complications, resolution of medical problems, and nutritional assessment over 2 years, including specific primary and secondary outcomes.
Key Findings:
RYGB and OAGB showed significant weight loss and improvement in associated medical problems, with specific statistical results to support these findings.
Interpretation:
Both RYGB and OAGB are effective revisional procedures after failed LSG, with similar outcomes in weight loss and complication rates, suggesting that OAGB can be a viable alternative to RYGB.
Limitations:
Limited sample size and short follow-up duration may affect the generalizability of the results, alongside potential biases due to single-center study design.
Conclusion:
The study supports the use of both RYGB and OAGB as effective options for patients experiencing weight regain after LSG, with OAGB emerging as a promising alternative, highlighting implications for clinical practice.
The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.
